Nachrichten zur Eli Lilly & Co. Aktie

Could Buying Eli Lilly Today Set You Up for Life?

Eli Lilly is leading the GLP-1 market, and investors are enthralled with the stock.…

Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know

The latest trading day saw Eli Lilly (LLY) settling at $916.31, representing a +1.47% change from its previous close.…

Want to Buy the Dip on Eli Lilly? Consider This Low-Cost Vanguard ETF

After nearly tripling between 2023 and the end of 2025, Lilly is undergoing a steep sell-off in 2026.…

Top Analyst Reports for Eli Lilly, RTX & Abbott

Eli Lilly leads top analyst picks as GLP-1 demand, pipeline advances, and global growth momentum drive strong outlook despite rising…

U.S. executives, from Apple to Eli Lilly, revamp their push into the worlds second-largest economy at the China Development Forum

More than 80 global executives traveled to Beijing this weekend for the state-organized China Development Forum.…

Heres How Much Upside Eli Lilly Stock Has, According to Analysts

Eli Lillys stock has been receiving many upgrades after posting strong quarterly results in February.…

Can Hims & Hers (HIMS) Turn Novo Nordisk Truce And New CCO Hire Into Lasting Brand Advantage?

Earlier in March 2026, Hims & Hers Health announced that Kathryn Beiser, a veteran of Discover, Kaiser Permanente, Eli Lilly,…

Should You Buy Eli Lilly Stock Before April 10?

A catalyst for stock performance may be just ahead.…

Beijing courts Eli Lilly as weight-loss drug race drives $3bn China commitment

Beijing courts Eli Lilly as weight-loss drug race drives $3bn China commitment…

LLYs Next-Gen Obesity Drug Meets Goal in First Phase III Study for T2D

Eli Lilly reports strong Phase III results for retatrutide in type 2 diabetes, with significant A1C reduction and up to…

Why Eli Lilly Remains My Top Obesity Bet

…

Lilly GLP-1 drug rivals Novos pipeline treatment on gut side effects but throws up skin concern

New trial data complicates the competitive picture in the fast-growing obesity drug market Eli Lilly and Cos (NYSE:LLY) experimental weight-loss…

OTC Markets Hosts Virtual Investor Presentation with H.H. Kim, CEO and President of MetaVia, and David Bautz, PhD, Senior Analyst at Zacks SCR

NASDAQ: MTVALili Elston: Hello, and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host,…

Best Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals

Both have plenty to offer investors, but one has a better outlook.…

Eli Lillys new shot shows solid weight loss in study — plus, a way for Nvidia to perk up

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.…

Is It Too Late to Buy Eli Lilly?

Eli Lillys GLP-1 drugs are leaders in a new and exciting drug category, but investors already know this fact.…

Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound…

Eli Lilly’s next-generation obesity drug delivers strong results in late-stage trial

Eli Lilly and Co (NYSE:LLY) has reported positive results from its late-stage trial of retatrutide, a next-generation obesity drug, demonstrating...…

Roche Vs. Eli Lilly: Nvidia Deals, Obesity Battles Stoke Rivalry (Id Buy Both)

…

Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics

Each of these companies could benefit from this high-growth market over time.…

HSBC drops blunt verdict on 150-year-old dividend stock

Eli Lilly has spent the last decade transforming from a reliable but unremarkable dividend payer into one of the most…

Eli Lilly (LLY) Stock Declines While Market Improves: Some Information for Investors

Eli Lilly (LLY) concluded the recent trading session at $930.5, signifying a -5.93% move from its prior days close.…

Stocks making the biggest moves midday: Mosaic, Tencent Music, Delta Air Lines, Uber, Eli Lilly & more

Here are some of the stocks making big headlines in midday trading.…

Stocks making the biggest moves premarket: Nvidia, Delta Air Lines, Eli Lilly & more

These are the stocks posting the largest moves premarket.…

Why Eli Lilly Stock Just Dropped

Eli Lillys stock price is based on growth rates that might fall short.…

Eli Lilly, Tencent Music among market cap stock movers on Tuesday

Eli Lilly, Tencent Music among market cap stock movers on Tuesday…

Is There Too Much Bullishness Priced Into Eli Lillys Stock Price?

Eli Lillys stock is down this year, and its high valuation may be a big reason why.…

Eli Lilly (LLY) to Invest $3 Billion in China Over the Next Decade, Reuters Reports

Eli Lilly and Company (NYSE:LLY) is one of the most profitable blue chip stocks to invest in now. Reuters reported…

Is Eli Lillys Weight Loss Empire in Trouble?

It wont be easy to knock the company off its pedestal.…

Will Policy Shifts Accelerate Demand for Eli Lillys GLP-1 Drugs?

LLY is likely to see stronger demand for its GLP-1 drugs as Medicare expands coverage and the company prepares to…

Former Eli Lilly executive joins Hims & Hers to lead communications during growth phase

Beiser joins the telehealth company from Eli Lilly as it expands internationally and builds out its Phoenix operations.…

Should You Chase the Rally in Hims & Hers Stock Today?

Hims & Hers shares extend gains as Eli Lilly warns impurity it discovered in compounded versions of its weight-loss drug…

Eli Lilly: The Weight-Loss Craze Isnt Over

…

Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks

Compounded weight-loss drugs that contain vitamin B12 and the main ingredient in Eli Lillys ?Zepbound could present health risks to…

Eli Lilly to invest $3 billion in China, seeks approval for new GLP-1 drug

Eli Lilly to invest $3 billion in China, seeks approval for new GLP-1 drug…

Hims And Hers Taps Veteran Communicator To Shape GLP 1 Growth Story

Hims & Hers Health (NYSE:HIMS) has appointed Kathryn Beiser as Chief Communications Officer.Beiser brings senior communications experience from Eli Lilly,…

Hims & Hers Names Kathryn Beiser as Chief Communications Officer

The global communications leader, who previously held roles at Eli Lilly and Kaiser Permanente, joins the world’s leading consumer health…

Hims & Hers Names Kathryn Beiser as Chief Communications Officer

The global communications leader, who previously held roles at Eli Lilly and Kaiser Permanente, joins the world’s leading consumer health…

Eli Lilly (LLY) Laps the Stock Market: Heres Why

In the closing of the recent trading day, Eli Lilly (LLY) stood at $1, denoting a +1.82% move from the…

Should You Buy Eli Lilly Stock Now or Wait for More of a Pullback?

Eli Lillys stock is a bit expensive, even with a bit of a decline this year.…

Zacks Market Edge Highlights: Caterpillar, Eli Lilly and Comfort Systems

Caterpillar, Eli Lilly and Comfort Systems have been highlighted in this Market Edge article.…

1 Dividend Stock to Buy Hand Over Fist and 1 to Avoid

Eli Lilly may be the GLP-1 leader, but its valuation is stretched.…

Where Will Eli Lilly Stock Be in 10 Years?

Eli Lilly is at the head of the pharma pack today, but in a decade, the situation could look very…

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

Pharmaceutical stocks like Eli Lilly and Merck are good places to help investors ride out a recent rise in geopolitical…

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Employers can use Lillys platform to connect with different third-party program administrators that help manage obesity treatment benefits and costs.…

Drugmaker Aspen targets Mounjaro approval in sub-Saharan Africa this year

Aspen Pharmacare aims to secure sub?Saharan African approval for Eli Lillys blockbuster weight?loss drug Mounjaro as early as this year,…

Rigel Pharma (RIGL) Earnings Call Transcript

Image source: The Motley Fool.DateTuesday, March 3, 2026 at 4:30 p.m. ETCall participantsChief Executive Officer — Raul R. RodriguezChief Commercial…

Up Over 400% in 5 Years, Is It Too Late to Invest in Eli Lilly Stock?

Key PointsEli Lillys stock has skyrocketed in value due to the success of its popular GLP-1 products.…

Up Over 400% in 5 Years, Is It Too Late to Invest in Eli Lilly Stock?

Eli Lilly has been a growth beast in recent years, but its valuation has gotten fairly high along the way.…

Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead?

Eli Lilly is making headlines in the pharmaceutical sector, but its a very expensive stock.…